Literature DB >> 30883041

Production of Viral Constructs for Neuroanatomy, Calcium Imaging, and Optogenetics.

Shih-Heng Chen1,2, Juhee Haam2, Mitzie Walker1,2, Erica Scappini3, John Naughton4, Negin P Martin1,2.   

Abstract

Advances in design and use of light-sensitive and light-emitting sensors have facilitated observation, measurement, and control of neuronal activities. Viruses are effective vectors for delivery of these valuable research tools to mammalian brains. Recombinant viruses are optimized to mediate regulatable, long-term, and cell-specific gene expression. Here, we describe production methods for three of the most commonly used types of recombinant viruses in neurobiology research: adeno-associated virus (AAV), retrovirus/lentivirus, and glycoprotein-deleted rabies virus. These viral constructs are frequently used for calcium imaging or to deliver neural tracers and optogenetic tools. Popular constructs are readily obtained commercially; however, customized virus production through commercial sources is time consuming and costly. This article aims to provide readers with detailed technical information for rapid production and validation of high-quality viral particles in a laboratory setting while highlighting advantages and limitations of each viral type.
© 2019 by John Wiley & Sons, Inc. © 2019 John Wiley & Sons, Inc.

Entities:  

Keywords:  AAVs; lentivirus; rabies delta-G; recombinant virus; retrovirus; viral production

Mesh:

Substances:

Year:  2019        PMID: 30883041      PMCID: PMC6530799          DOI: 10.1002/cpns.66

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  27 in total

1.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield.

Authors:  S Zolotukhin; B J Byrne; E Mason; I Zolotukhin; M Potter; K Chesnut; C Summerford; R J Samulski; N Muzyczka
Journal:  Gene Ther       Date:  1999-06       Impact factor: 5.250

2.  Adeno-associated viral vectors found free in media.

Authors:  Xiao Xiao
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

3.  Millisecond-timescale, genetically targeted optical control of neural activity.

Authors:  Edward S Boyden; Feng Zhang; Ernst Bamberg; Georg Nagel; Karl Deisseroth
Journal:  Nat Neurosci       Date:  2005-08-14       Impact factor: 24.884

4.  A simple method for organotypic cultures of nervous tissue.

Authors:  L Stoppini; P A Buchs; D Muller
Journal:  J Neurosci Methods       Date:  1991-04       Impact factor: 2.390

5.  Synapse elimination accompanies functional plasticity in hippocampal neurons.

Authors:  Natalia Bastrikova; Gregory A Gardner; Jeff M Reece; Andreas Jeromin; Serena M Dudek
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

6.  Directed differentiation of hippocampal stem/progenitor cells in the adult brain.

Authors:  Sebastian Jessberger; Nicolas Toni; Gregory D Clemenson; Jasodhara Ray; Fred H Gage
Journal:  Nat Neurosci       Date:  2008-06-29       Impact factor: 24.884

7.  Production and titration of lentiviral vectors.

Authors:  Patrick Salmon; Didier Trono
Journal:  Curr Protoc Hum Genet       Date:  2007-07

Review 8.  Production and titration of lentiviral vectors.

Authors:  Patrick Salmon; Didier Trono
Journal:  Curr Protoc Neurosci       Date:  2006-11

9.  Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery.

Authors:  N D Mazarakis; M Azzouz; J B Rohll; F M Ellard; F J Wilkes; A L Olsen; E E Carter; R D Barber; D F Baban; S M Kingsman; A J Kingsman; K O'Malley; K A Mitrophanous
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

10.  Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.

Authors:  Martin Lock; Mauricio Alvira; Luk H Vandenberghe; Arabinda Samanta; Jaan Toelen; Zeger Debyser; James M Wilson
Journal:  Hum Gene Ther       Date:  2010-10       Impact factor: 5.695

View more
  6 in total

1.  In Vivo Two-photon Calcium Imaging in Dendrites of Rabies Virus-labeled V1 Corticothalamic Neurons.

Authors:  Yajie Tang; Liang Li; Leqiang Sun; Jinsong Yu; Zhe Hu; Kaiqi Lian; Gang Cao; Jinxia Dai
Journal:  Neurosci Bull       Date:  2019-12-05       Impact factor: 5.203

2.  AAV diffuses across zona pellucida for effortless gene delivery to fertilized eggs.

Authors:  Charles Romeo; Shih-Heng Chen; Eugenia Goulding; Lucas Van Gorder; Maura Schwartz; Mitzie Walker; Gregory Scott; Erica Scappini; Manas Ray; Negin P Martin
Journal:  Biochem Biophys Res Commun       Date:  2020-03-17       Impact factor: 3.575

3.  Automated Live-Cell Imaging of Synapses in Rat and Human Neuronal Cultures.

Authors:  Matthew V Green; Thomas Pengo; Jonathan D Raybuck; Tahmina Naqvi; Hannah M McMullan; Jon E Hawkinson; Ezequiel Marron Fernandez de Velasco; Brian S Muntean; Kirill A Martemyanov; Rachel Satterfield; Samuel M Young; Stanley A Thayer
Journal:  Front Cell Neurosci       Date:  2019-10-17       Impact factor: 5.505

4.  Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological and pathological disease in a Syrian hamster model of COVID-19.

Authors:  Thomas J Esparza; Yaozong Chen; Negin P Martin; Helle Bielefeldt-Ohmann; Richard A Bowen; William D Tolbert; Marzena Pazgier; David L Brody
Journal:  bioRxiv       Date:  2021-11-12

5.  Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19.

Authors:  Thomas J Esparza; Yaozong Chen; Negin P Martin; Helle Bielefeldt-Ohmann; Richard A Bowen; William D Tolbert; Marzena Pazgier; David L Brody
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

6.  High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme.

Authors:  Thomas J Esparza; Negin P Martin; George P Anderson; Ellen R Goldman; David L Brody
Journal:  Sci Rep       Date:  2020-12-22       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.